• 2844 Citations
  • 21 h-Index
20042019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Luca Toschi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Gene Dosage Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

  • 2844 Citations
  • 21 h-Index
  • 47 Article
  • 2 Review article
2 Citations (Scopus)

Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations

Passaro, A., Prelaj, A., Bonanno, L., Tiseo, M., Tuzi, A., Proto, C., Chiari, R., Rocco, D., Genova, C., Sini, C., Cortinovis, D., Pilotto, S., Landi, L., Bennati, C., Camerini, A., Toschi, L., Putzu, C., Cerea, G., Spitaleri, G., Cappuzzo, F. & 1 others, de Marinis, F., Mar 1 2019, In : Clinical Lung Cancer. 20, 2, p. e186-e194

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Mutation
Exons
Point Mutation

Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations

Passaro, A., Prelaj, A., Bonanno, L., Tiseo, M., Tuzi, A., Proto, C., Chiari, R., Rocco, D., Genova, C., Sini, C., Cortinovis, D., Pilotto, S., Landi, L., Bennati, C., Camerini, A., Toschi, L., Putzu, C., Cerea, G., Spitaleri, G., Cappuzzo, F. & 1 others, de Marinis, F., Nov 20 2018, In : Clinical Lung Cancer. 9 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Mutation
Exons
1 Citation (Scopus)

Checkpoint inhibitors: 'Raising the bar' also in brain metastases from non-small-cell lung cancer?

Rossi, S., Finocchiaro, G., Marchetti, S., Toschi, L. & Santoro, A., Apr 1 2018, In : Immunotherapy. 10, 5, p. 403-410 8 p.

Research output: Contribution to journalReview article

Non-Small Cell Lung Carcinoma
Neoplasm Metastasis
Brain
Oncogenes
Patient Selection
3 Citations (Scopus)

Immunotherapy in non-small-cell lung cancer: Potential predictors of response and new strategies to assess activity

Rossi, S., Castello, A., Toschi, L. & Lopci, E., Jul 1 2018, In : Immunotherapy. 10, 9, p. 797-805 9 p.

Research output: Contribution to journalReview article

Non-Small Cell Lung Carcinoma
Immunotherapy
Patient Selection
Immunosuppressive Agents
Biomarkers
1 Citation (Scopus)

Impact of Exon 19 Deletion Subtypes in EGFR-Mutant Metastatic Non–Small-Cell Lung Cancer Treated With First-Line Tyrosine Kinase Inhibitors

Rossi, S., Toschi, L., Finocchiaro, G., Di Noia, V., Bonomi, M., Cerchiaro, E., Ceresoli, G. L., Beretta, G. D., D'Argento, E. & Santoro, A., Jan 1 2018, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Exons
Disease-Free Survival